Stay updated on Risdiplam in SMA Type 2/3: Clinical Trial
Sign up to get notified when there's something new on the Risdiplam in SMA Type 2/3: Clinical Trial page.

Latest updates to the Risdiplam in SMA Type 2/3: Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoNo Change Detected
- Check20 days agoChange DetectedThe page’s revision/version label was updated from v3.5.2 to v3.5.3.SummaryDifference0.0%

- Check27 days agoChange Detected- Revision updated from v3.5.0 to v3.5.2.SummaryDifference0.0%

- Check56 days agoChange DetectedAdded Revision: v3.5.0 and removed Revision: v3.4.3 in the Study Documents section.SummaryDifference0.0%

- Check70 days agoChange DetectedRevision updated from v3.4.2 to v3.4.3. This appears to be a metadata update with no visible changes to core content.SummaryDifference0.0%

- Check92 days agoChange DetectedRevision badge updated from v3.4.1 to v3.4.2 on the page. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check100 days agoChange DetectedRevision label updated from v3.4.0 to v3.4.1. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

Stay in the know with updates to Risdiplam in SMA Type 2/3: Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Risdiplam in SMA Type 2/3: Clinical Trial page.